1. Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial). Issue 10 (5th July 2019) Authors: Johansen, Marie L.; Schou, Morten; Rossignol, Patrick; Holm, Maria R.; Rasmussen, Jon; Brandt, Niels; Frandsen, Mikkel; Chabanova, Elizaveta; Dela, Flemming; Faber, Jens; Kistorp, Caroline Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 10(2019) Page Start: 2305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗